Tretinoin (all-trans retinoic acid) is the gold standard topical retinoid with 50+ years of clinical evidence — the only retinoid with FDA approval for both acne (1971) and photoaging (1995), and the benchmark against which all newer retinoids are compared. Despite being among the most evidence-supported topical medications in dermatology, tretinoin remains underutilized due to initiation side effects, patient adherence challenges, and confusion about optimal concentration selection.
Mechanism and Concentration Evidence
Tretinoin activates nuclear retinoic acid receptors (RARα, RARβ, RARγ) → regulates hundreds of genes involved in keratinocyte differentiation, collagen synthesis (type I and III), fibroblast stimulation, MMP inhibition (reducing collagen degradation), angiogenesis, and pigmentation regulation. Concentration evidence: Kligman's landmark photoaging RCT (1986, NEJM): tretinoin 0.1% produced significant wrinkle reduction, hyperpigmentation improvement, and collagen synthesis at 16 weeks — the pivotal study establishing photoaging efficacy. Comparative concentration RCTs: 0.025% shows similar efficacy to 0.05% for photoaging with significantly less irritation — the optimal starting concentration for most patients. 0.1% produces modestly greater collagen induction but 3–5× more irritation — appropriate for experienced users or refractory photodamage. For acne: 0.025% shows comparable comedolytic efficacy to 0.1% in several head-to-head trials — the higher concentration is rarely necessary for comedonal acne.
Managing the Purge and Building Tolerance
Initial tretinoin purge: 2–6 weeks of increased breakouts as accelerated epidermal turnover brings subclinical microcomedones to the surface — normal and predictable, not an allergic reaction. Management: warn patients beforehand, advise continuing through purge, avoid other acutely irritating actives during initiation. Retinization (barrier disruption during initial use): peeling, erythema, dryness — minimize with: start 0.025%, apply every 3rd night for 2 weeks → every other night × 2 weeks → nightly. Apply after moisturizer ("sandwich method" — moisturizer → tretinoin → moisturizer) reduces irritation without significantly reducing efficacy. Sun protection: tretinoin increases photosensitivity by 15–20% — morning SPF 30+ is non-negotiable. Adapalene 0.3% (now OTC in US): comparable efficacy to tretinoin 0.025% for acne with significantly lower irritation — appropriate starting point for tretinoin-naive patients. Our skin care catalog includes complementary barrier products supporting retinoid users' skin health management.
